Lecturer Professor of Pharmacology at the Faculty of Pharmacy and Food Science at the University of Barcelona (UB) since 2020. He received his Ph.D in the epigenetic modulation of Alzheimer’s disease (AD) (Biomedical Biotechnology) in 2016 at the UB. During  doctoral thesis, he focused his knowledge in the epigenetic modulation of neurodegeneration and AD. Furthermore, the study of non-pharmacological interventions such as Environmental Enrichment (EE) paradigms in order to find new targets to prevent or cure the cognitive decline. His current research interest is the development of new chemical entities based on epigenetics to ameliorate and to prevent neurodegenerative diseases, including rare disease. He is also interested in the implications of the transgenerational epigenetic inheritance in the cognitive decline risk for the next generation. Pharmacology and drug discovery are the principle topics of his teaching activities in the Faculty of Pharmacy. He belongs to network GENiE from 2021

Ramón y Cajal Researcher at the Faculty of Pharmacy and Food Science of the University of Barcelona (UB) since 2023. She completed her PhD in Molecular Medicine at the University of Santiago de Compostela (USC), and held postdoctoral positions at the MRC London Institute of Medical Sciences (MRC LMS, Imperial College London, UK) and the UK Dementia Research Institute (UK DRI at University College London, The Francis Crick Institute, UK). Her postdoctoral research explored the potential of cellular senescence as a therapeutic target, leading to the identification of novel pharmacological modulators of senescence, including senolytic compounds (Guerrero et al. 2019, Nature Metabolism; Guerrero et al. 2020, Aging Cell) and drugs alleviating senescence (Guerrero et al. 2022, Nature Aging). Her current research programme explores the contribution of cellular senescence and ageing to neurodegeneration, with a particular focus on Alzheimer´s Disease.

ORCID es 0000-0002-4622-9201

I am a Pharmacy graduate by the University of Barcelona. As an undergraduate student, I spent time in the Neurosciences group led by Dr. M. Pallàs and Dr. C. Griñán-Ferré participating in different research projects. After graduating, I had the opportunity to do an internship in the Neurosciences Group in Maciel Group  (Universidade do Minho, Braga), where I learned to work with C. Elegans through the study of new targets for Machado Joseph disease. In October 2020, I started my PhD studying the role of the histone methyltransferase G9a/GLP  in neurodegeneration using C. elegans and mice as experimental models.

In 2019, I finished my studies of Human Biology in the Universitat Pompeu Fabra (UPF). Then, I studied a Master of Neuroscience in the Universitat de Barcelona (UB) and I performed my master thesis in the Neuropharmacology of Aging and Neurodegeneration group, in the Faculty of Pharmacy and Food Science. At present, I’m a Ph.D. student at the same laboratory under the supervision of Dr. M.Pallàs and Dr. C. Griñán-Ferré. In particular, I’m studying the behavioral and biochemical changes that cause the pharmacological inhibition of the soluble epoxide hydrolase enzyme in Alzheimer’s Disease using mice and C. elegans animal models.

Graduate in Biochemistry and Molecular Biology at the University Rovira i Virgili  and Master student of Biomedical Research Student at the University Pompeu Fabra. She joined Neuropharmacology of Aging and Neurodegeneration group, in the Faculty of Pharmacy and Food Science, under Dr Griñán Ferré supervision  to pursuit her PhD thesis on Pharmacological targets related with neuroepigenetic mechanisms.

ORCID: 0000-0002-5850-5058

She is a Pharmacy graduated from National University of Asunción (Paraguay). At 2021, She finished MSc program in Pharmaceutical Sciences (National University of Asunción, Paraguay). During the career and the MSc program, she has been involved in research projects about medicinal drugs and their effect in CNS. Recently she joined at the Dr. M. Pallàs and Dr. C. Griñán team, as an PhD student at Faculty of Pharmacy and Food Science at the Universitat de Barcelona, in the Neuropharmacology of Aging and Neurodegeneration group, to search the molecular pathways involved in the Alzheimer Disease and other neurodegenerative diseases. She is interested in new drugs to face cognitive decline in ageing and neurodegenerative diseases that exert effect at the Imidazoline receptors (I₂-IR) in mice and the molecular pathways involved in their effect.

ORCID: 0000-0002-9666-333X